Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GLAXF - Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis

GLAXF - Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis

GlaxoSmithKline Plc

2024-07-17 16:47:26 ET

Summary

  • VIR develops medicines for infectious and viral diseases using proprietary platforms for monoclonal antibodies and T cell-based Viral Vectors.
  • Positive Phase 2 trial results for chronic hepatitis delta highlight the company's potential to address unmet medical needs.
  • Strategic collaborations include the Bill & Melinda Gates Foundation, Alnylam Pharmaceuticals, and Gilead Sciences.
  • The company has substantial liquid resources and no financial debt, supporting a compelling valuation.
  • I believe VIR is undervalued tapping into significant TAMs, making it a "strong buy."

...

For further details see:

Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis
Stock Information
Company Name: GlaxoSmithKline Plc
Stock Symbol: GLAXF
Market: OTC
Website: gsk.com
Menu
GLAXF GLAXF Quote GLAXF Short GLAXF News GLAXF Articles GLAXF Message Board
Get GLAXF Alerts

News, Short Squeeze, Breakout and More Instantly...